These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 3098684)

  • 1. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation.
    Jarvis GA; Vedros NA
    Infect Immun; 1987 Jan; 55(1):174-80. PubMed ID: 3098684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human IgA1 blockade of IgG-initiated lysis of Neisseria meningitidis is a function of antigen-binding fragment binding to the polysaccharide capsule.
    Jarvis GA; Griffiss JM
    J Immunol; 1991 Sep; 147(6):1962-7. PubMed ID: 1909736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human IgA1 initiates complement-mediated killing of Neisseria meningitidis.
    Jarvis GA; Griffiss JM
    J Immunol; 1989 Sep; 143(5):1703-9. PubMed ID: 2474610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis.
    Vogel U; Weinberger A; Frank R; Müller A; Köhl J; Atkinson JP; Frosch M
    Infect Immun; 1997 Oct; 65(10):4022-9. PubMed ID: 9317002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci.
    Marques MB; Kasper DL; Pangburn MK; Wessels MR
    Infect Immun; 1992 Oct; 60(10):3986-93. PubMed ID: 1398910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative roles of factor H binding protein, neisserial surface protein A, and lipooligosaccharide sialylation in regulation of the alternative pathway of complement on meningococci.
    Lewis LA; Carter M; Ram S
    J Immunol; 2012 May; 188(10):5063-72. PubMed ID: 22504643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of C3 deposition and degradation on Neisseria meningitidis and Neisseria gonorrhoeae.
    Jarvis GA
    Infect Immun; 1994 May; 62(5):1755-60. PubMed ID: 8168937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG.
    Selander B; Käyhty H; Wedege E; Holmström E; Truedsson L; Söderström C; Sjöholm AG
    J Clin Immunol; 2000 Mar; 20(2):138-49. PubMed ID: 10821465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement-mediated bactericidal activity of human antibodies to poly alpha 2-->8 N-acetylneuraminic acid, the capsular polysaccharide of Neisseria meningitidis serogroup B.
    Mandrell RE; Azmi FH; Granoff DM
    J Infect Dis; 1995 Nov; 172(5):1279-89. PubMed ID: 7594665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway.
    Kochi SK; Johnson RC
    Infect Immun; 1988 Feb; 56(2):314-21. PubMed ID: 3276623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis.
    Skevakis L; Frasch CE; Zahradnik JM; Dolin R
    J Infect Dis; 1984 Mar; 149(3):387-96. PubMed ID: 6425422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-dependent alternative pathway killing of Haemophilus influenzae type b.
    Steele NP; Munson RS; Granoff DM; Cummins JE; Levine RP
    Infect Immun; 1984 May; 44(2):452-8. PubMed ID: 6609128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined roles of human IgG subclass, alternative complement pathway activation, and epitope density in the bactericidal activity of antibodies to meningococcal factor h binding protein.
    Giuntini S; Reason DC; Granoff DM
    Infect Immun; 2012 Jan; 80(1):187-94. PubMed ID: 22064712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal activity for Neisseria meningitidis in properdin-deficient sera.
    Söderström C; Braconier JH; Danielsson D; Sjöholm AG
    J Infect Dis; 1987 Jul; 156(1):107-12. PubMed ID: 3110302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum.
    Kahler CM; Martin LE; Shih GC; Rahman MM; Carlson RW; Stephens DS
    Infect Immun; 1998 Dec; 66(12):5939-47. PubMed ID: 9826376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vaccinated individuals serum bactericidal activity against B meningococci is abrogated by C5 inhibition but not by inhibition of the alternative complement pathway.
    Ispasanie E; Muri L; Schmid M; Schubart A; Thorburn C; Zamurovic N; Holbro T; Kammüller M; Pluschke G
    Front Immunol; 2023; 14():1180833. PubMed ID: 37457736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein.
    Hong K; Kinoshita T; Takeda J; Kozono H; Pramoonjago P; Kim YU; Inoue K
    Infect Immun; 1990 Aug; 58(8):2535-41. PubMed ID: 2142480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor H-dependent alternative pathway inhibition mediated by porin B contributes to virulence of Neisseria meningitidis.
    Lewis LA; Vu DM; Vasudhev S; Shaughnessy J; Granoff DM; Ram S
    mBio; 2013 Oct; 4(5):e00339-13. PubMed ID: 24129254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation and formation of the membrane attack complex on serogroup B Neisseria meningitidis in the presence or absence of serum bactericidal activity.
    Drogari-Apiranthitou M; Kuijper EJ; Dekker N; Dankert J
    Infect Immun; 2002 Jul; 70(7):3752-8. PubMed ID: 12065518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.